Moleculin Biotech, Inc. · NASDAQ:MBRX

Klemp Walter V exercised options for 207,500 Moleculin Biotech, Inc. shares (Form 4)

Traded Oct 15, 2026 · Filed Oct 16, 2026

On Oct 15, 2026, Klemp Walter V (Director, CEO and President) exercised options for 207,500 Moleculin Biotech, Inc. shares, leaving 723,181 shares. Filed Oct 16, 2026 (Form 4).

Options exercised
207,500 shares
Holding after
723,181 shares
Trading plan
No
Role
Director, CEO and President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 15, 2026Common StockOption exercise207,500771,840Direct
Oct 15, 2026Common StockShares withheld for tax48,659US$0.37723,181Direct

Source

Download original · View original at SEC

Related